Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_provenance.
- NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_assertion description "[PLTP activity and apoE were measured in patients with type 2 diabetes from the DALI (Diabetes Atorvastatin Lipid Intervention) Study, a 30-week randomized double-blind placebo-controlled trial with atorvastatin (10 and 80 mg daily).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_provenance.
- NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_assertion evidence source_evidence_literature NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_provenance.
- NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_assertion SIO_000772 16644710 NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_provenance.
- NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_assertion wasDerivedFrom befree-20150227 NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_provenance.
- NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_assertion wasGeneratedBy ECO_0000203 NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP631600.RA3UyKCT4g5_QbWtxaWxcTfN51k82slS4sxt5b0EJtAN8130_provenance.